AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
INSULIN GLULISINE
3 registrations across 3 African markets— 3 active
Markets with INSULIN GLULISINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| APIDRA SOLOSTAR 100 UI/ ML SOLUTION INJECTABLE EN SC EN STYLOS PRE-REMPLIS FLACON DE 3ML | 🇨🇮Côte d'Ivoire | SANOFI-AVENTIS DEUTSCHLAND GMBH | active | Feb 2029 |
| APIDRA SOLOSTAR Solution for injection | 🇹🇿Tanzania | Ressourceethica/Propharmed INTL | active | — |
| Apidra 100 IU/mL Solution for Injection in a Vial Solution for injection | 🇳🇬Nigeria | — | active | — |
INSULIN GLULISINE in Africa — Regulatory Overview
INSULIN GLULISINE is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Nigeria, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 3 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.